Source: Wikimedia Commons and David S. Soriano
Everlit Audio Player
Subscribe today to listen to this content Get Access

The U.S. Food and Drug Administration (FDA) has introduced its first internal generative AI tool which it has anthropomorphized as “Elsa’” For internal use only, Elsa will assess technology and assist with regulatory oversight.

According to the FDA, Elsa will be a welcome revolution.


Subscribe to continue reading

  • Unlimited access to our content and archive
  • Exclusive access to our newsletter
  • Join the Conversation! Exclusive access to article comments.